US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Tevogen Inc. - Warrant (NQ:TVGNW)

0.0637 +0.0024 (+3.92%)
Delayed Quote Updated: 3:20 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tevogen Inc. - Warrant

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
Both previously disclosed Nasdaq compliance matters are now closed 
From Tevogen Inc.
Via GlobeNewswire
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
From Tevogen Bio Inc
Via GlobeNewswire
Unusual volume stocks in Monday's session ↗
Via Chartmill
On Friday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
News headline image
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
From Tevogen Bio Inc
Via GlobeNewswire
Here are the top movers in Thursday's session. ↗
Via Chartmill
Top movers in Thursday's session ↗
Via Chartmill
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Tevogen Announces Formation of a Healthcare Services Initiative
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
From Tevogen Bio Inc
Via GlobeNewswire
Gapping stocks in Tuesday's session ↗
Via Chartmill
News headline image
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Letter to Shareholders from CEO Dr. Ryan Saadi
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
From Tevogen Bio Inc
Via GlobeNewswire
Top movers in Monday's pre-market session ↗
Via Chartmill
News headline image
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
From Tevogen Bio Inc
Via GlobeNewswire
Top stock movements in today's session. ↗
Via Chartmill
Monday's session: top gainers and losers ↗
Via Chartmill
Gapping stocks in Monday's session ↗
Via Chartmill
News headline image
Tevogen Names Leadership Team to Execute Diversified Growth Strategy
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Letter to Shareholders from CEO Dr. Ryan Saadi
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Announces Reverse Stock Split
From Tevogen Bio Inc
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >